abs145.txt	treatment	of	hepatocellular	carcinoma	(hcc)	requires	sustained	suppression	oftumor	cell	growth	and	metastasis	for	long-term	efficacy		however	traditionalintratumoral	drug	delivery	system	always	exhibits	burst	release	with	lesstherapeutic	outcomes	here	a	new	self-assembling	amphiphilic	peptide	drugconjugate	(saapdc)	is	fabricated	as	two-in-one	nanofiber	comprising	ahexapeptide	matrix	metalloproteinases	(mmp)	inhibitor	doxorubicin	(dox)for	the	hcc	results	indicate	that	doxorubicin-conjugatedpeptide	(dox-kgfrwr)	self-assembles	to	form	long	nanofibers	showing	sustainedrelease	property	inhibiting	enzymatic	activities	mmp-2	mmp-9	thisnanofiber	not	only	inhibits	tumor	in	situ	but	also	effectively	preventspulmonary	an	smmc7721	line-based	mouse	model	summary	thishexapeptide-based	supermolecule	represents	promising	nanoscale	platformto	sustain	high	loading	capacity	intratumoraladministration	moreover	chemotherapeutic	drugs	via	drug-bearingsupramolecular	mmp	simultaneously	andtumor	achieve	synergistic	effects	metastatic	therapy
